{
  "name": "Corcept Therapeutics Inc",
  "legal_name": "CORCEPT THERAPEUTICS INC",
  "ticker": "CORT",
  "tickers": [
    "CORT"
  ],
  "cik": "0001088856",
  "page_url": "https://steadybase.io/company/corcept-therapeutics-inc/",
  "markdown_url": "https://steadybase.io/company/corcept-therapeutics-inc.md",
  "json_url": "https://steadybase.io/company/corcept-therapeutics-inc.json",
  "as_of": "2026-11-10",
  "last_filed": "2026-11-03",
  "industry": {
    "sic": "2834",
    "description": "Pharmaceutical Preparations"
  },
  "headquarters": {
    "city": "Redwood City",
    "state": "CA",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "Large accelerated filer",
  "state_of_incorporation": "DE",
  "website": "corcept.com",
  "investor_relations_url": null,
  "linkedin_company_url": "https://www.linkedin.com/company/corcept-therapeutics",
  "summary": {
    "text": "We are a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.",
    "section": "Item 1. Business",
    "period_end": "2025-12-31",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/cort-20251231.htm"
  },
  "key_facts": [
    {
      "key": "revenue",
      "label": "Revenue",
      "value": 761407000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-02-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html",
      "text": "Revenue: $761.4M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026)."
    },
    {
      "key": "operating_income",
      "label": "Operating income",
      "value": 44797000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-02-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html",
      "text": "Operating income: $44.8M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026)."
    },
    {
      "key": "net_income",
      "label": "Net income",
      "value": 99652000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-02-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html",
      "text": "Net income: $99.7M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026)."
    },
    {
      "key": "sga",
      "label": "SG&A",
      "value": 448725000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-02-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html",
      "text": "SG&A: $448.7M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026)."
    },
    {
      "key": "employees",
      "label": "Employees",
      "value": 730,
      "unit": "people",
      "period_end": "2025-12-31",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/cort-20251231.htm",
      "text": "Employees: 730 as of Dec 31, 2025, as reported in an SEC filing."
    },
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 109443109,
      "unit": "shares",
      "period_end": "2026-10-22",
      "form": "10-Q",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069501/0001628280-26-069501-index.html",
      "text": "Shares outstanding: 109,443,109 as of Oct 22, 2026 (10-Q filed Nov 3, 2026)."
    },
    {
      "key": "auditor",
      "label": "Auditor",
      "value": "Ernst & Young LLP",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/cort-20251231.htm",
      "text": "Auditor: Ernst & Young LLP, San Mateo, California, named in the latest 10-K."
    }
  ],
  "metrics": {
    "revenue": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 761407000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 675040000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 482375000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 401858000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-02-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828025008167/0001628280-25-008167-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": 365978000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-02-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828024005055/0001628280-24-005055-index.html"
      }
    ],
    "operating_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 44797000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 136951000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 107282000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 112634000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-02-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828025008167/0001628280-25-008167-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": 124477000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-02-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828024005055/0001628280-24-005055-index.html"
      }
    ],
    "net_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 99652000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 141209000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 106140000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 101418000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-02-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828025008167/0001628280-25-008167-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": 112512000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-02-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828024005055/0001628280-24-005055-index.html"
      }
    ],
    "sga": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 448725000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 280320000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2023-01-01",
        "period_end": "2023-12-31",
        "value": 184259000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-02-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.html"
      },
      {
        "period_start": "2022-01-01",
        "period_end": "2022-12-31",
        "value": 152848000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2025-02-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828025008167/0001628280-25-008167-index.html"
      },
      {
        "period_start": "2021-01-01",
        "period_end": "2021-12-31",
        "value": 122356000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2024-02-15",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828024005055/0001628280-24-005055-index.html"
      }
    ]
  },
  "next_earnings": {
    "date": "2027-02-08",
    "confidence": "estimate",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Joseph K. Belanoff",
      "title": "MD, Corcept’s Chief Executive Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/joe-belanoff-b240618",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort110326ex991pressrelease.htm"
    },
    {
      "name": "Atabak Mokari",
      "title": "Chief Financial Officer",
      "role": "officer",
      "linkedin_url": "https://www.linkedin.com/in/atabak-mokari-03454012",
      "form": "4",
      "filed": "2026-09-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526382463/0001193125-26-382463-index.htm"
    },
    {
      "name": "Roberto Wandenkolk Vieira",
      "title": "President, Oncology",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-09-18",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526395837/0001193125-26-395837-index.htm"
    },
    {
      "name": "Bill Guyer",
      "title": "PharmD, Corcept’s Chief Development Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort110326ex991pressrelease.htm"
    },
    {
      "name": "Gary Charles Robb",
      "title": "Chief Business Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-09-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526405402/0001193125-26-405402-index.htm"
    },
    {
      "name": "William Guyer",
      "title": "Chief Development Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-09-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526382475/0001193125-26-382475-index.htm"
    },
    {
      "name": "Hazel Hunt",
      "title": "Chief Scientific Officer",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/hazel-hunt-6624198",
      "form": "4",
      "filed": "2026-03-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526089012/0001193125-26-089012-index.htm"
    },
    {
      "name": "G. Leonard Baker, Jr.",
      "title": "director",
      "role": "director",
      "linkedin_url": null,
      "form": "8-K",
      "filed": "2026-05-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/cort-20260521.htm"
    },
    {
      "name": "Gregg Alton",
      "title": "director",
      "role": "director",
      "linkedin_url": null,
      "form": "8-K",
      "filed": "2026-05-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/cort-20260521.htm"
    },
    {
      "name": "Charles Robb",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Daniel N. Swisher, Jr.",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "David L. Mahoney",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Hazel Hunt, Ph.D.",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "James N. Wilson",
      "title": "Board member (per proxy)",
      "role": "both",
      "linkedin_url": "https://linkedin.com/in/james-wilson-3750b4376",
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Joseph D. Lyon",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Joseph K. Belanoff, M.D.",
      "title": "Board member (per proxy)",
      "role": "both",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Joshua M. Murray",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Kimberly Park",
      "title": "Board member (per proxy)",
      "role": "director",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "Sean Maduck",
      "title": "President, Corcept Endocrinology",
      "role": "officer",
      "linkedin_url": "https://linkedin.com/in/sean-maduck-9092bb1",
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    },
    {
      "name": "William Guyer, Pharm.D.",
      "title": "Named in proxy",
      "role": "officer",
      "linkedin_url": null,
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-11-03",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort-20261103.htm"
    },
    {
      "filed": "2026-09-23",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526398561/d148256d8k.htm"
    },
    {
      "filed": "2026-07-29",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026050607/cort-20260729.htm"
    },
    {
      "filed": "2026-06-17",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526274258/d159941d8k.htm"
    },
    {
      "filed": "2026-06-03",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526254622/d103585d8k.htm"
    },
    {
      "filed": "2026-05-28",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        },
        {
          "item": "5.07",
          "label": "Submission of matters to a vote of security holders",
          "signal": "governance"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/cort-20260521.htm"
    },
    {
      "filed": "2026-04-30",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026028892/cort-20260430.htm"
    },
    {
      "filed": "2026-03-25",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526123543/d123475d8k.htm"
    },
    {
      "filed": "2026-02-24",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011080/cort-20260224.htm"
    },
    {
      "filed": "2026-02-19",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526059551/d25779d8k.htm"
    }
  ],
  "insider_trades": [
    {
      "owner": "Roberto Wandenkolk Vieira",
      "role": "President, Oncology",
      "action": "sold",
      "code": "S",
      "shares": 8333,
      "value_usd": 674069,
      "date": "2026-11-02",
      "filed": "2026-11-04",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526447899/0001193125-26-447899-index.htm"
    },
    {
      "owner": "James N. Wilson",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 10000,
      "value_usd": 1148083,
      "date": "2026-10-15",
      "filed": "2026-10-16",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526424350/0001193125-26-424350-index.htm"
    },
    {
      "owner": "Roberto Wandenkolk Vieira",
      "role": "President, Oncology",
      "action": "sold",
      "code": "S",
      "shares": 8333,
      "value_usd": 967448,
      "date": "2026-10-02",
      "filed": "2026-10-05",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526414688/0001193125-26-414688-index.htm"
    },
    {
      "owner": "Joseph Douglas Lyon",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 10000,
      "value_usd": 1160731,
      "date": "2026-10-02",
      "filed": "2026-10-05",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526414684/0001193125-26-414684-index.htm"
    },
    {
      "owner": "Sean Maduck",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 25000,
      "value_usd": 2906601,
      "date": "2026-10-02",
      "filed": "2026-10-05",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526414674/0001193125-26-414674-index.htm"
    },
    {
      "owner": "Roberto Wandenkolk Vieira",
      "role": "President, Oncology",
      "action": "sold",
      "code": "S",
      "shares": 296,
      "value_usd": 29843,
      "date": "2026-09-16",
      "filed": "2026-09-18",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526395837/0001193125-26-395837-index.htm"
    },
    {
      "owner": "James N. Wilson",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 10000,
      "value_usd": 1106932,
      "date": "2026-09-15",
      "filed": "2026-09-16",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526393124/0001193125-26-393124-index.htm"
    },
    {
      "owner": "Joseph Douglas Lyon",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 10000,
      "value_usd": 1134950,
      "date": "2026-09-14",
      "filed": "2026-09-16",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526393125/0001193125-26-393125-index.htm"
    },
    {
      "owner": "Roberto Wandenkolk Vieira",
      "role": "President, Oncology",
      "action": "sold",
      "code": "S",
      "shares": 58333,
      "value_usd": 6460755,
      "date": "2026-09-02",
      "filed": "2026-09-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526382456/0001193125-26-382456-index.htm"
    },
    {
      "owner": "Sean Maduck",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 25000,
      "value_usd": 2860771,
      "date": "2026-09-01",
      "filed": "2026-09-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526382474/0001193125-26-382474-index.htm"
    },
    {
      "owner": "Kimberly Park",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 26685,
      "value_usd": 3270247,
      "date": "2026-08-26",
      "filed": "2026-08-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526374607/0001193125-26-374607-index.htm"
    },
    {
      "owner": "Sean Maduck",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 30955,
      "value_usd": 3887387,
      "date": "2026-08-25",
      "filed": "2026-08-27",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/0001193125-26-371388-index.htm"
    },
    {
      "owner": "David L. Mahoney",
      "role": "Director",
      "action": "sold",
      "code": "S",
      "shares": 103606,
      "value_usd": 12251611,
      "date": "2026-08-18",
      "filed": "2026-08-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526359255/0001193125-26-359255-index.htm"
    },
    {
      "owner": "Gary Charles Robb",
      "role": "Chief Business Officer",
      "action": "sold",
      "code": "S",
      "shares": 10000,
      "value_usd": 1162600,
      "date": "2026-08-17",
      "filed": "2026-08-18",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526355560/0001193125-26-355560-index.htm"
    },
    {
      "owner": "Sean Maduck",
      "role": "See Remarks",
      "action": "sold",
      "code": "S",
      "shares": 3664,
      "value_usd": 419491,
      "date": "2026-08-14",
      "filed": "2026-08-18",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/0001193125-26-355563-index.htm"
    }
  ],
  "quotes": [
    {
      "text": "Awareness of the importance of diagnosing and treating patients with Cushing’s syndrome is steadily increasing and is driving the growth of our endocrinology business",
      "speaker": "Joseph K. Belanoff",
      "title": "MD, Corcept’s Chief Executive Officer",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort110326ex991pressrelease.htm"
    },
    {
      "text": "The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome",
      "speaker": "Bill Guyer",
      "title": "PharmD, Corcept’s Chief Development Officer",
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort110326ex991pressrelease.htm"
    }
  ],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069494/cort-20261103.htm"
    },
    {
      "form": "10-K",
      "filed": "2026-02-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/cort-20251231.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-11-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026069501/cort-20260930.htm"
    },
    {
      "form": "DEF 14A",
      "filed": "2026-04-17",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1088856/000162828026025735/cort-20260417.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}